Zynerba (ZYNE) stock forecast for 2023. Forecast tables and graphs.

Zynerba (ZYNE) stock forecast for 2023

The forecast has been updated: June 24, 2021 7:37


Zynerba stock price online today

Analyst Target Price

7.63

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $7.63 target price for Zynerba stock stock.

Today 200 Day Moving Average is the support level (4.5092 $).

50 Day Moving Average is the support level (4.9917 $).




ZYNE Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 6.15 5.85 6.68 12.43 %
Feb 6.21 5.74 6.49 11.54 %
Mar 5.79 5.53 6.06 8.77 %
Apr 5.63 5.11 6.08 15.99 %
May 4.75 4.37 5.33 18.09 %
Jun 4.60 4.09 4.98 17.95 %
Jul 4.60 4.10 5.23 21.53 %
Aug 5.05 4.58 5.26 12.79 %
Sep 5.04 4.49 5.22 13.90 %
Oct 5.38 4.68 6.05 22.74 %
Nov 5.68 5.03 6.50 22.66 %
Dec 5.03 4.42 5.43 18.51 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.


Zynerba overview

Zynerba Address

80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US

Market Capitalization

229 770 864 $

EBITDA

-36 895 716

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.892

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

397.6066

EV To EBITDA

0

52 Week High

9

52 Week Low

3.12

50 Day Moving Average

4.9917

200 Day Moving Average

4.5092

Shares Outstanding

41251500

Shares Float

39132584

Shares Short Prior Month

3611879

Short Ratio

1.3

Percent Insiders

2.604

Percent Institutions

32.242

Zynerba stock forecast for this year


Zynerba stock forecast for Jan 2023.
Estimated Average Forecasted Zynerba Price: 6.15. Positive monthly dynamics of the instrument is expected with 12.426% volatility is expected.

Pessimistic forecast: 5.85

Optimistic: 6.68


Zynerba stock forecast for Feb 2023.
Estimated Average Forecasted Zynerba Price: 6.21. Positive monthly dynamics of the instrument is expected with 11.541% volatility is expected.

Pessimistic forecast: 5.74

Optimistic: 6.49


Zynerba stock forecast for Mar 2023.
Estimated Average Forecasted Zynerba Price: 5.79. Negative monthly dynamics of the instrument is expected with 8.770% volatility is expected.

Pessimistic forecast: 5.53

Optimistic: 6.06


Zynerba stock forecast for Apr 2023.
Estimated Average Forecasted Zynerba Price: 5.63. Negative monthly dynamics of the instrument is expected with 15.985% volatility is expected.

Pessimistic forecast: 5.11

Optimistic: 6.08


Zynerba stock forecast for May 2023.
Estimated Average Forecasted Zynerba Price: 4.75. Negative monthly dynamics of the instrument is expected with 18.093% volatility is expected.

Pessimistic forecast: 4.37

Optimistic: 5.33


Zynerba stock forecast for Jun 2023.
Estimated Average Forecasted Zynerba Price: 4.60. Negative monthly dynamics of the instrument is expected with 17.953% volatility is expected.

Pessimistic forecast: 4.09

Optimistic: 4.98


Zynerba stock forecast for Jul 2023.
Estimated Average Forecasted Zynerba Price: 4.60. Negative monthly dynamics of the instrument is expected with 21.534% volatility is expected.

Pessimistic forecast: 4.10

Optimistic: 5.23


Zynerba stock forecast for Aug 2023.
Estimated Average Forecasted Zynerba Price: 5.05. Positive monthly dynamics of the instrument is expected with 12.791% volatility is expected.

Pessimistic forecast: 4.58

Optimistic: 5.26


Zynerba stock forecast for Sep 2023.
Estimated Average Forecasted Zynerba Price: 5.04. Negative monthly dynamics of the instrument is expected with 13.900% volatility is expected.

Pessimistic forecast: 4.49

Optimistic: 5.22


Zynerba stock forecast for Oct 2023.
Estimated Average Forecasted Zynerba Price: 5.38. Positive monthly dynamics of the instrument is expected with 22.736% volatility is expected.

Pessimistic forecast: 4.68

Optimistic: 6.05


Zynerba stock forecast for Nov 2023.
Estimated Average Forecasted Zynerba Price: 5.68. Positive monthly dynamics of the instrument is expected with 22.657% volatility is expected.

Pessimistic forecast: 5.03

Optimistic: 6.50


Zynerba stock forecast for Dec 2023.
Estimated Average Forecasted Zynerba Price: 5.03. Negative monthly dynamics of the instrument is expected with 18.514% volatility is expected.

Pessimistic forecast: 4.42

Optimistic: 5.43



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 111.7 (24.06.2021) 0.78 %
AbbVie Inc.
ABBV 114.74 (24.06.2021) 0.65 %
Aeterna Zentaris Inc.
AEZS 0.9101 (23.06.2021) 4.01 %
Allakos Inc.
ALLK 94.26 (24.06.2021) 3.31 %
Allogene Therapeutics, Inc.
ALLO 24.16 (24.06.2021) 2.85 %
Amgen Inc.
AMGN 240.95 (24.06.2021) 0.94 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.58 (24.06.2021) 6.97 %
Aurora Cannabis Inc.
ACB 9.35 (24.06.2021) 3.66 %
Becton Dickinson and Company
BDX 239.82 (24.06.2021) -0.17 %
Biogen Inc.
BIIB 349.16 (24.06.2021) -6.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 97.27 (24.06.2021) -0.46 %
BioNTech SE
BNTX 227.79 (24.06.2021) -0.75 %
bluebird bio, Inc.
BLUE 32.33 (24.06.2021) -0.12 %
Boston Scientific Corp.
BSX 43.71 (24.06.2021) -0.18 %
Bristol-Myers Squibb Company
BMY 65.85 (24.06.2021) 0.90 %
Canopy Growth Corp.
CGC 24.72 (24.06.2021) 4.88 %
Castle Biosciences, Inc.
CSTL 75.09 (24.06.2021) 0.55 %
Eli Lilly and Company
LLY 232.97 (24.06.2021) 7.31 %
Emergent BioSolutions Inc.
EBS 61.85 (24.06.2021) 3.00 %
Exelixis, Inc.
EXEL 22.86 (24.06.2021) 2.88 %
G1 Therapeutics, Inc.
GTHX 23.27 (24.06.2021) 6.55 %
Gilead Sciences, Inc.
GILD 67.18 (24.06.2021) 0.80 %
GlaxoSmithKline plc
GSK 39.7 (24.06.2021) -0.38 %
GoodRx Holdings, Inc.
GDRX 38.94 (24.06.2021) 1.83 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 86.13 (24.06.2021) 1.17 %
Inovio Pharmaceuticals, Inc.
INO 8.89 (24.06.2021) 2.30 %
Johnson & Johnson
JNJ 163.37 (24.06.2021) 0.46 %
Medtronic plc.
MDT 125.09 (24.06.2021) -0.32 %
Merck & Co., Inc.
MRK 76.36 (24.06.2021) 1.03 %
Moderna, Inc.
MRNA 220.14 (24.06.2021) 3.82 %
Novartis AG
NVS 92.46 (24.06.2021) 0.08 %
Novavax, Inc.
NVAX 192.48 (24.06.2021) 0.12 %
ObsEva SA
OBSV 3.01 (23.06.2021) 2.38 %
OrganiGram Holdings Inc.
OGI 3.07 (24.06.2021) 3.37 %
Pfizer Inc.
PFE 39.19 (24.06.2021) 0.36 %
Regeneron Pharmaceuticals, Inc.
REGN 544.45 (24.06.2021) 2.77 %
Sanofi
SNY 52.32 (24.06.2021) 0.46 %
Schrodinger, Inc.
SDGR 78.46 (24.06.2021) 2.07 %
Senseonics Holdings, Inc.
SENS 3.61 (24.06.2021) 0.56 %
Sorrento Therapeutics, Inc.
SRNE 9.04 (23.06.2021) 1.23 %
Stryker Corp.
SYK 261.39 (24.06.2021) -0.48 %
Sundial Growers Inc.
SNDL 1 (24.06.2021) 0.00 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.42 (24.06.2021) 2.16 %
Thermo Fisher Scientific Inc.
TMO 495.36 (24.06.2021) 0.27 %
Tilray, Inc.
TLRY 18.26 (24.06.2021) 3.69 %
UnitedHealth Group, Inc.
UNH 398.87 (24.06.2021) 0.84 %
Veeva Systems Inc.
VEEV 312 (24.06.2021) 0.28 %
Zomedica Corp.
ZOM 0.8401 (24.06.2021) -0.88 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.77 (24.06.2021) 3.59 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.